News & Updates

American College of Cardiology International Conferences Cardiovascular disease Dyslipidemia management Dyslipidemia

On July 22, 2023, the Philippine College of Endocrinology Diabetes and Metabolism in partnership with P&G health presented a landmark event entitled “1-Stop Shop Concept for Screening of Diabetes Complications Including Diabetic Peripheral Neuropathy.”

On July 22, 2023, the Philippine College of Endocrinology Diabetes and Metabolism in partnership with P&G health presented a landmark event entitled “1-Stop Shop Concept for Screening of Diabetes Complications Including Diabetic Peripheral Neuropathy.” 

Product Highlight - IVCORT

Hydrocortisone Na succinate 100 mg powd for inj

EMPULSE trial confirms the efficacy and safety profile of empagliflozin in patients stabilized in hospital following acute heart failure

Empagliflozin is the first SGLT-2i to significantly improve outcomes for patients with HF in any setting (in-hospital/outpatient), across the full spectrum of HF. Results from the EMPULSE trial showed that patients hospitalized for acute HF who were treated with empagliflozin following stabilization had 36% clinical benefit on the composite of mortality, HF events, and KCCQ-TSS improvement. The EMPULSE trial also provides a reassuring safety profile for empagliflozin that is consistent with previous trials.

GLP-1 RA Diabetes Mellitus Type 2 Diabetes Management Dulaglutide

Product Highlight - ROSUZET

Ezetimibe, rosuvastatin 10 mg/10 mg FC tab

Emerging organ protective therapies in T2DM

The goals of diabetes care are to prevent complications and optimize quality of life. Current developments in diabetes management have shifted focus from just glycemic control to the inclusion of organ protection. In the Boehringer Ingelheim-sponsored webinar entitled “Deep dive in EMPA-KIDNEY” held last December 9, 2022, Dr Nestor Eric Laplano, Consultant, Skyline Hospital and Medical Center and Grace General Hospital, SJDM Bulacan; and Dr David Cherney, Active Consultant, University Health Network and Mount Sinai Hospital Toronto Canada, revisited treatment strategies and discussed the EMPA-KIDNEY trial and its implications in organ protective therapies for type 2 diabetes.

[ Dr David Cherney ]
Dr David Cherney
Speaker

[ Dr Nestor Eric Laplano ]
Dr Nestor Eric Laplano
Moderator

Put Life Back in Your Patients’ Hands: Winning the fight Against Peripheral Neuropathy in Diabetic Patients

Dear Doctor,  

In celebration of World Diabetes Day, P&G Health Philippines, in partnership with the Philippine Association of Family Physicians (PAFP), Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM), and the Cavite Medical Society (CMS) recently held the “Put Life Back in Your Patients’ Hands: Winning the Fight against Neuropathy in Diabetes” physical-digital event for healthcare professionals, we made sure you don’t miss the updates and innovations in nerve care that were discussed. 

Catch the highlights of the “phygital” event here.  

Diabetes Mellitus DMT2 GLP1-RA Dulaglutide

Zvolution - Making Healthcare More Accessible

Staying true to its long history of committed partnership with healthcare professionals on Continuing Medical Education (CME) and product innovation, ZP Therapeutics made a grand return to face-to-face CME events in celebration of ZP Therapeutics’ illustrious 100-year history as a leading healthcare industry partner. The ZPT Exposition of Experts in Improving Patient Outcomes 2022, themed “Zvolution -Making Healthcare More Accessible”, was held at the Conrad Hotel in Pasay City last 23–24 September 2022 and featured a panel of top-notch speakers whose talks covered a broad range of topics from digital health solutions to Gastroenterology, bone health, immunity as well as critical care in diabetes, and Cardiology.